Cytogenetic and Molecular Response to Imatinib in High Risk (Sokal) Chronic Myeloid Leukemia (CML): Results of An European Leukemianet Prospective Study Comparing 400 Mg and 800 Mg Front-Line | AVESİS

Hacettepe University Research Information System

Cytogenetic and Molecular Response to Imatinib in High Risk (Sokal) Chronic Myeloid Leukemia (CML): Results of An European Leukemianet Prospective Study Comparing 400 Mg and 800 Mg Front-Line

Copy For Citation

Baccarani M., Castagnetti F., Simonsson B., Porkka K., HAZNEDAROĞLU İ. C., Nagler A., ...More

50th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2008, vol.112, pp.75-76

Publication Type: Conference Paper / Summary Text
Volume: 112
City: San-Francisco
Country: Costa Rica
Page Numbers: pp.75-76
Hacettepe University Affiliated: Yes